Navigation Links
Dey Pharma Commemorates 14th Annual Food Allergy Awareness Week
Date:5/10/2011

risk for anaphylaxis.(6) There are approximately 50 to 2,000 episodes of anaphylaxis per every 100,000 people globally, translating to a 0.05% to 2.0% lifetime prevalence of anaphylaxis.(7) The precise incidence of anaphylaxis is unknown because this serious, life-threatening condition is believed to be underreported.(7) Failure to inject epinephrine promptly is associated with fatal anaphylaxis.(5)

About EpiPen Auto-Injector

EpiPen® and EpiPen Jr (0.3 and 0.15 mg epinephrine) Auto-Injectors are for the emergency treatment of severe allergic reactions (anaphylaxis).  As with any medication, EpiPen Auto-Injector has an expiration date printed directly on the side of the auto-injector and end side of the carton and should be replaced when the unit expires. The product should be stored at room temperature, protected from light and never refrigerated or kept where it might be exposed to extreme temperatures, such as in the glove compartment of a car.

Dey Pharma, L.P., the distributor of EpiPen Auto-Injector, offers patient support through a program that has a free membership at www.myepipen.com.  This program provides helpful tips, resources and an expiration reminder program.

Indication

EpiPen and EpiPen Jr (0.3 and 0.15 mg epinephrine) Auto-Injectors are for the emergency treatment of severe allergic reactions (anaphylaxis) caused by allergens, exercise, or unknown triggers; and for people who are at increased risk for these reactions. EpiPen and EpiPen Jr are designed for immediate use in an emergency, to treat a severe allergic reaction fast and give you time to get to a hospital or medical center. EpiPen and EpiPen Jr are not a substitute for emergency medical treatment.

Important Safety Information

EpiPen Auto-Injectors contain a single dose of epinephrine, which you inject into your outer thigh. DO NOT INJECT INTRAVENOUSLY. DO NOT INJEC
'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015 Cogentix Medical, Inc. (NASDAQ: ... urology market, will release financial results for the first quarter ... the market close on Monday, August 10, 2015. ... to discuss these results on Monday, August 10, 2015 at ... Kill , President and Chief Executive Officer, and Brett ...
(Date:7/29/2015)... Calif. , July 29, 2015  AcelRx ... pharmaceutical company focused on the development and commercialization ... and breakthrough pain, today announced that it will ... on Monday, Aug 3rd, 2015. AcelRx management will ... Eastern Time (1:30 p.m. Pacific Time) on Aug ...
(Date:7/29/2015)... MOUNTAIN VIEW, Calif. , July 29, 2015 /PRNewswire/ ... in the growth strategy of pharmaceutical firms in ... . The realization is that an effective working ... sales, pricing pressures and patent cliffs. Big pharma companies ... bolster returns. Logo - http://photos.prnewswire.com/prnh/20150724/241957LOGO ...
Breaking Medicine Technology:Cogentix Medical to Announce First Quarter Fiscal 2016 Results on August 10, 2015 2AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 2AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 3AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 4Working Capital Management Seizes Priority in North American and European Pharma Industry 2Working Capital Management Seizes Priority in North American and European Pharma Industry 3Working Capital Management Seizes Priority in North American and European Pharma Industry 4
... Nov. 20 Smith & Nephew ( SNN, LSE: SN) ... technology development contract with the United States Department of Defense ... system intended to revolutionize the treatment of the limbs of ... Advanced Research Projects Agency (DARPA), the central research and development ...
... 19 In response to an ever-increasing number of ... involving 24 countries, was coordinated by INTERPOL and the ... to highlight the dangers of buying medicines online. , ... of arrests and the seizure of thousands of potentially ...
Cached Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2
(Date:7/29/2015)... ... ... Today marks a significant achievement in bringing new monies into early stage ... by a group of experienced investors, has tapped into an investor community passionate about ... a part of the fund. The Sofia Fund II is now closed to ...
(Date:7/29/2015)... ... 2015 , ... July is National UV Awareness Month, and in honor of this month, Dr. ... to protect skin from the sun, as well as how to best treat existing sun ... the most common skin conditions in America. Many people do not protect their skin sufficiently ...
(Date:7/29/2015)... Madison, Wis. (PRWEB) , ... July 29, 2015 ... ... enrolled its first two patients in a Clinical Performance Study for the Invisiport ... includes 4.4 and 6 French catheter options, offers a less invasive, patient-friendly alternative ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... a “forward thinker.” Since the late 1970s, Dr. Cottrell has been making predictions ... book, The New Earth, documents many of these prognostications. He warns that extreme ...
(Date:7/29/2015)... ... July 29, 2015 , ... HealthPostures ( ... a partnership with 247Ergo, an ergonomics specialty firm. Purpose of the partnership is ... the companies undertake could improve worker mobility, functionality and fitness levels. , ...
Breaking Medicine News(10 mins):Health News:Sofia Fund Surpasses Investor Goals 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 3Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 3
... February 2009 Nearly half of patients with heart ... of cognitive functioning, reports a new study published by ... Cardiac Failure ( http://www.elsevier.com/locate/cardfail ). , Memory ... factor to consider in planning medical care for patients ...
... 5 Medifast, Inc. (NYSE: MED ... that Executive Chairman of the Board Bradley MacDonald ... Founded in 1992, Leadership Maryland is an independent, ... from the public and private sectors about the ...
... recently debuted to help service providers and medical practices strengthen their ... practices the edge needed to build their businesses. , ... ... providers and physicians in search of a customized approach to ...
... MinuteClinic, the pioneer and largest provider of retail ... it has become a participating provider in the ... Carolina.BlueCross, Preferred Blue and Medicare Advantage members now ... located in the Columbia and Greenville markets. BlueCross ...
... half wait at least a month before seeking help, ... Most breast cancers in Hispanic women are detected by ... population, a new study shows. , What,s troubling, however, ... an abnormality during a self-exam waited at least a ...
... high standards set by independent scientific association to ... According to a new set of guidelines ... Probiotics and Prebiotics (ISAPP) there are five key ... probiotic product -- strain specificity, clinical proof, packaging, ...
Cached Medicine News:Health News:Heart failure linked to cognitive impairment 2Health News:Executive Chairman of Medifast Bradley MacDonald Selected to Participate in Leadership Maryland 2Health News:Executive Chairman of Medifast Bradley MacDonald Selected to Participate in Leadership Maryland 3Health News:Medical Marketing Firm Builds Service Provider and Medical Practice Bottom Lines 2Health News:Medical Marketing Firm Builds Service Provider and Medical Practice Bottom Lines 3Health News:MinuteClinic Becomes Participating Provider With Preferred Blue Network of BlueCross BlueShield of South Carolina 2Health News:Two-Thirds of Hispanic Women Discover Breast Cancer Themselves 2Health News:Align(R) Daily Probiotic Supplement Meets New Consumer Guidelines 2Health News:Align(R) Daily Probiotic Supplement Meets New Consumer Guidelines 3Health News:Align(R) Daily Probiotic Supplement Meets New Consumer Guidelines 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: